DiaMedica Inc. to Deliver Poster Presentation at World Conference on Clinical Pharmacology and Therapeutics

WINNIPEG, MANITOBA--(Marketwire - July 30, 2008) - DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and development company focused on novel treatments for Type 2 diabetes, announces that it will be presenting results of a study at the 9th World Conference on Clinical Pharmacology and Therapeutics (www.cpt2008.org) in Quebec City, Canada today.

Back to news